Recently our Founder and CEO, Reginald Swift, sat down with the team at Pharma Tech Outlook magazine to discuss the changes happening with the pharma industry and how digital health, particularly virtual clinical trials are mobilizing access of pipeline therapeutics to the world for various disease states.

An article to the discussion can be found here:

Rubix LS – Pharma Tech Outlook Article